Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

Related Articles by Review for PubMed (Select 16573311)

1.

Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy.

Bailey RK, Mallinckrodt CH, Wohlreich MM, Watkin JG, Plewes JM.

J Natl Med Assoc. 2006 Mar;98(3):437-47.

2.

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.

Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV.

Hum Psychopharmacol. 2005 Jul;20(5):327-41. Review.

PMID:
15912562
3.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
4.

Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.

Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.

Int J Clin Pract. 2007 Aug;61(8):1337-48. Review.

PMID:
17627710
5.

Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.

Reddy S, Kane C, Pitrosky B, Musgnung J, Ninan PT, Guico-Pabia CJ.

Curr Med Res Opin. 2010 Jan;26(1):139-50. doi: 10.1185/03007990903408678. Review.

PMID:
19919295
6.

Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.

Cowen PJ, Ogilvie AD, Gama J.

Curr Med Res Opin. 2005 Mar;21(3):345-56. Review.

PMID:
15811202
7.

Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

Hunziker ME, Suehs BT, Bettinger TL, Crismon ML.

Clin Ther. 2005 Aug;27(8):1126-43. Review.

PMID:
16199241
8.

Duloxetine in the management of elderly patients with major depressive disorder: an analysis of published data.

Mancini M, Gianni W, Rossi A, Amore M.

Expert Opin Pharmacother. 2009 Apr;10(5):847-60. doi: 10.1517/14656560902806431 . Review.

PMID:
19351233
9.

Duloxetine in the treatment of major psychiatric and neuropathic disorders.

Müller N, Schennach R, Riedel M, Möller HJ.

Expert Rev Neurother. 2008 Apr;8(4):527-36. doi: 10.1586/14737175.8.4.527. Review.

PMID:
18416656
10.

Duloxetine: a review of its use in the treatment of major depressive disorder.

Frampton JE, Plosker GL.

CNS Drugs. 2007;21(7):581-609. Review.

PMID:
17579500
11.

Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression.

Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM.

J Affect Disord. 2005 Jul;87(1):115-9. Review.

PMID:
15967235
12.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
13.

Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 4:46-52. Review.

PMID:
15046541
14.

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.

Ball SG, Desaiah D, Zhang Q, Thase ME, Perahia DG.

Drugs Context. 2013 Jan 3;2013:212245. doi: 10.7573/dic.212245. eCollection 2013 Jan 3. Review.

15.

Duloxetine: in patients with fibromyalgia.

Curran MP.

Drugs. 2009 Jun 18;69(9):1217-27. doi: 10.2165/00003495-200969090-00006. Review.

PMID:
19537838
16.

Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder.

Perry R, Cassagnol M.

Clin Ther. 2009 Jun;31 Pt 1:1374-404. doi: 10.1016/j.clinthera.2009.07.012. Review.

PMID:
19698900
17.

The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S.

Curr Pharm Des. 2005;11(12):1475-93. Review.

PMID:
15892657
18.

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.

Mancini M, Perna G, Rossi A, Petralia A.

Expert Opin Pharmacother. 2010 May;11(7):1167-81. doi: 10.1517/14656561003747441. Review. Erratum in: Expert Opin Pharmacother. 2010 Jun;11(8):1443.

PMID:
20402555
19.

Duloxetine: a dual reuptake inhibitor.

Dugan SE, Fuller MA.

Ann Pharmacother. 2004 Dec;38(12):2078-85. Epub 2004 Nov 2. Review.

PMID:
15522980
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk